UniProt ID | GGA1_HUMAN | |
---|---|---|
UniProt AC | Q9UJY5 | |
Protein Name | ADP-ribosylation factor-binding protein GGA1 | |
Gene Name | GGA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 639 | |
Subcellular Localization |
Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein. Endosome membrane Peripheral membrane protein. |
|
Protein Description | Plays a role in protein sorting and trafficking between the trans-Golgi network (TGN) and endosomes. Mediates the ARF-dependent recruitment of clathrin to the TGN and binds ubiquitinated proteins and membrane cargo molecules with a cytosolic acidic cluster-dileucine (AC-LL) motif.. | |
Protein Sequence | MEPAMEPETLEARINRATNPLNKELDWASINGFCEQLNEDFEGPPLATRLLAHKIQSPQEWEAIQALTVLETCMKSCGKRFHDEVGKFRFLNELIKVVSPKYLGSRTSEKVKNKILELLYSWTVGLPEEVKIAEAYQMLKKQGIVKSDPKLPDDTTFPLPPPRPKNVIFEDEEKSKMLARLLKSSHPEDLRAANKLIKEMVQEDQKRMEKISKRVNAIEEVNNNVKLLTEMVMSHSQGGAAAGSSEDLMKELYQRCERMRPTLFRLASDTEDNDEALAEILQANDNLTQVINLYKQLVRGEEVNGDATAGSIPGSTSALLDLSGLDLPPAGTTYPAMPTRPGEQASPEQPSASVSLLDDELMSLGLSDPTPPSGPSLDGTGWNSFQSSDATEPPAPALAQAPSMESRPPAQTSLPASSGLDDLDLLGKTLLQQSLPPESQQVRWEKQQPTPRLTLRDLQNKSSSCSSPSSSATSLLHTVSPEPPRPPQQPVPTELSLASITVPLESIKPSNILPVTVYDQHGFRILFHFARDPLPGRSDVLVVVVSMLSTAPQPIRNIVFQSAVPKVMKVKLQPPSGTELPAFNPIVHPSAITQVLLLANPQKEKVRLRYKLTFTMGDQTYNEMGDVDQFPPPETWGSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEPAMEPE -------CCCCCCHH | 14.54 | 22814378 | |
15 | Ubiquitination | ETLEARINRATNPLN HHHHHHHHHHCCCCH | 23.21 | 21963094 | |
23 | Ubiquitination | RATNPLNKELDWASI HHCCCCHHCCCHHHH | 68.30 | - | |
23 | Ubiquitination | RATNPLNKELDWASI HHCCCCHHCCCHHHH | 68.30 | 23000965 | |
28 | Ubiquitination | LNKELDWASINGFCE CHHCCCHHHHHHHHH | 10.53 | 21890473 | |
28 | Ubiquitination | LNKELDWASINGFCE CHHCCCHHHHHHHHH | 10.53 | 23000965 | |
46 | Ubiquitination | EDFEGPPLATRLLAH CCCCCCHHHHHHHHH | 9.52 | 25015289 | |
54 (in isoform 2) | Ubiquitination | - | 36.51 | 21890473 | |
54 | Ubiquitination | ATRLLAHKIQSPQEW HHHHHHHHCCCHHHH | 36.51 | - | |
57 (in isoform 6) | Phosphorylation | - | 31.83 | 24043423 | |
57 (in isoform 5) | Phosphorylation | - | 31.83 | 24043423 | |
68 (in isoform 6) | Phosphorylation | - | 26.51 | 24043423 | |
68 (in isoform 5) | Phosphorylation | - | 26.51 | 24043423 | |
69 | Ubiquitination | EAIQALTVLETCMKS HHHHHHHHHHHHHHH | 4.77 | 24816145 | |
73 | Glutathionylation | ALTVLETCMKSCGKR HHHHHHHHHHHCCHH | 2.06 | 22555962 | |
88 | Ubiquitination | FHDEVGKFRFLNELI HHHHHHHHHHHHHHH | 5.70 | 23000965 | |
92 | Ubiquitination | VGKFRFLNELIKVVS HHHHHHHHHHHHHHC | 39.04 | 21890473 | |
92 | Ubiquitination | VGKFRFLNELIKVVS HHHHHHHHHHHHHHC | 39.04 | 22817900 | |
93 | Ubiquitination | GKFRFLNELIKVVSP HHHHHHHHHHHHHCH | 54.76 | 21890473 | |
96 | Ubiquitination | RFLNELIKVVSPKYL HHHHHHHHHHCHHHC | 49.56 | 23000965 | |
99 | Phosphorylation | NELIKVVSPKYLGSR HHHHHHHCHHHCCCC | 20.75 | - | |
101 | Ubiquitination | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 23000965 | |
101 | Ubiquitination | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 21890473 | |
101 (in isoform 1) | Ubiquitination | - | 45.67 | 21890473 | |
101 | Malonylation | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 30639696 | |
101 | Malonylation | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 26320211 | |
101 | Acetylation | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 25953088 | |
105 | Ubiquitination | VSPKYLGSRTSEKVK HCHHHCCCCCCHHHH | 29.77 | 23000965 | |
105 | Phosphorylation | VSPKYLGSRTSEKVK HCHHHCCCCCCHHHH | 29.77 | 22798277 | |
108 | Phosphorylation | KYLGSRTSEKVKNKI HHCCCCCCHHHHHHH | 34.02 | 22798277 | |
110 | Ubiquitination | LGSRTSEKVKNKILE CCCCCCHHHHHHHHH | 59.27 | 23000965 | |
113 | Ubiquitination | RTSEKVKNKILELLY CCCHHHHHHHHHHHH | 39.32 | 23000965 | |
118 | Ubiquitination | VKNKILELLYSWTVG HHHHHHHHHHHHHCC | 4.95 | 23000965 | |
122 | Ubiquitination | ILELLYSWTVGLPEE HHHHHHHHHCCCCHH | 4.99 | 29967540 | |
125 | Ubiquitination | LLYSWTVGLPEEVKI HHHHHHCCCCHHHHH | 28.30 | 32015554 | |
132 (in isoform 2) | Ubiquitination | - | 5.17 | 21890473 | |
133 | Ubiquitination | LPEEVKIAEAYQMLK CCHHHHHHHHHHHHH | 6.94 | 24816145 | |
140 | Acetylation | AEAYQMLKKQGIVKS HHHHHHHHHCCCCCC | 37.39 | 25953088 | |
141 | Acetylation | EAYQMLKKQGIVKSD HHHHHHHHCCCCCCC | 50.20 | 25953088 | |
141 (in isoform 2) | Ubiquitination | - | 50.20 | 21890473 | |
141 | Ubiquitination | EAYQMLKKQGIVKSD HHHHHHHHCCCCCCC | 50.20 | - | |
147 | Phosphorylation | KKQGIVKSDPKLPDD HHCCCCCCCCCCCCC | 48.53 | 28348404 | |
155 | Phosphorylation | DPKLPDDTTFPLPPP CCCCCCCCCCCCCCC | 37.40 | 28348404 | |
156 | Phosphorylation | PKLPDDTTFPLPPPR CCCCCCCCCCCCCCC | 30.19 | 20068231 | |
157 | Ubiquitination | KLPDDTTFPLPPPRP CCCCCCCCCCCCCCC | 6.76 | 21890473 | |
158 | Ubiquitination | LPDDTTFPLPPPRPK CCCCCCCCCCCCCCC | 41.69 | - | |
165 (in isoform 2) | Ubiquitination | - | 66.19 | 21890473 | |
165 | Ubiquitination | PLPPPRPKNVIFEDE CCCCCCCCCCCCCCH | 66.19 | 21890473 | |
165 | Ubiquitination | PLPPPRPKNVIFEDE CCCCCCCCCCCCCCH | 66.19 | 22817900 | |
165 (in isoform 1) | Ubiquitination | - | 66.19 | 21890473 | |
174 (in isoform 1) | Ubiquitination | - | 54.02 | 21890473 | |
174 | Ubiquitination | VIFEDEEKSKMLARL CCCCCHHHHHHHHHH | 54.02 | 21906983 | |
175 | Ubiquitination | IFEDEEKSKMLARLL CCCCHHHHHHHHHHH | 26.95 | 25015289 | |
182 | Ubiquitination | SKMLARLLKSSHPED HHHHHHHHHCCCHHH | 4.16 | 22817900 | |
183 | Ubiquitination | KMLARLLKSSHPEDL HHHHHHHHCCCHHHH | 55.28 | 33845483 | |
183 | Methylation | KMLARLLKSSHPEDL HHHHHHHHCCCHHHH | 55.28 | - | |
184 | Phosphorylation | MLARLLKSSHPEDLR HHHHHHHCCCHHHHH | 33.57 | 30108239 | |
185 | Phosphorylation | LARLLKSSHPEDLRA HHHHHHCCCHHHHHH | 41.28 | 30108239 | |
191 | Ubiquitination | SSHPEDLRAANKLIK CCCHHHHHHHHHHHH | 43.93 | 33845483 | |
191 | Ubiquitination | SSHPEDLRAANKLIK CCCHHHHHHHHHHHH | 43.93 | 21890473 | |
192 | Ubiquitination | SHPEDLRAANKLIKE CCHHHHHHHHHHHHH | 23.76 | 25015289 | |
195 | Acetylation | EDLRAANKLIKEMVQ HHHHHHHHHHHHHHH | 47.03 | 25953088 | |
195 | Ubiquitination | EDLRAANKLIKEMVQ HHHHHHHHHHHHHHH | 47.03 | 29967540 | |
198 | Ubiquitination | RAANKLIKEMVQEDQ HHHHHHHHHHHHHHH | 50.63 | 33845483 | |
198 (in isoform 1) | Ubiquitination | - | 50.63 | 21890473 | |
200 | Ubiquitination | ANKLIKEMVQEDQKR HHHHHHHHHHHHHHH | 2.99 | 33845483 | |
200 | Ubiquitination | ANKLIKEMVQEDQKR HHHHHHHHHHHHHHH | 2.99 | - | |
206 | Ubiquitination | EMVQEDQKRMEKISK HHHHHHHHHHHHHHH | 67.06 | 24816145 | |
215 | Ubiquitination | MEKISKRVNAIEEVN HHHHHHHHHHHHHHH | 6.97 | 21890473 | |
215 | Ubiquitination | MEKISKRVNAIEEVN HHHHHHHHHHHHHHH | 6.97 | 33845483 | |
223 | Ubiquitination | NAIEEVNNNVKLLTE HHHHHHHHHHHHHHH | 60.90 | 24816145 | |
223 | Ubiquitination | NAIEEVNNNVKLLTE HHHHHHHHHHHHHHH | 60.90 | - | |
236 | Phosphorylation | TEMVMSHSQGGAAAG HHHHHHCCCCCCCCC | 24.18 | 17525332 | |
244 | Phosphorylation | QGGAAAGSSEDLMKE CCCCCCCCHHHHHHH | 26.31 | 28348404 | |
245 | Phosphorylation | GGAAAGSSEDLMKEL CCCCCCCHHHHHHHH | 33.92 | 28348404 | |
262 | Phosphorylation | RCERMRPTLFRLASD HHHHHCHHHHHHHCC | 28.32 | - | |
268 | Phosphorylation | PTLFRLASDTEDNDE HHHHHHHCCCCCCHH | 50.05 | 28348404 | |
270 | Phosphorylation | LFRLASDTEDNDEAL HHHHHCCCCCCHHHH | 42.62 | 27273156 | |
355 | Phosphorylation | EQPSASVSLLDDELM CCCCCEEEECCHHHH | 22.25 | 12060753 | |
359 | Ubiquitination | ASVSLLDDELMSLGL CEEEECCHHHHHCCC | 51.39 | 29967540 | |
373 | Ubiquitination | LSDPTPPSGPSLDGT CCCCCCCCCCCCCCC | 65.62 | 29967540 | |
412 | Phosphorylation | ESRPPAQTSLPASSG CCCCCCCCCCCCCCC | 34.05 | 24275569 | |
418 | Phosphorylation | QTSLPASSGLDDLDL CCCCCCCCCCCHHHH | 45.54 | 14702039 | |
434 | Phosphorylation | GKTLLQQSLPPESQQ HHHHHHHCCCHHHHH | 29.86 | 28857561 | |
446 | Ubiquitination | SQQVRWEKQQPTPRL HHHCHHHHCCCCCCE | 47.47 | 29967540 | |
450 | Phosphorylation | RWEKQQPTPRLTLRD HHHHCCCCCCEEHHH | 19.39 | - | |
463 | Ubiquitination | RDLQNKSSSCSSPSS HHHCCCCCCCCCCCH | 36.65 | - | |
478 | Phosphorylation | SATSLLHTVSPEPPR HHHHHHHHCCCCCCC | 23.73 | 26074081 | |
480 | Phosphorylation | TSLLHTVSPEPPRPP HHHHHHCCCCCCCCC | 25.38 | 26074081 | |
493 | Phosphorylation | PPQQPVPTELSLASI CCCCCCCCEEEEEEE | 50.20 | 30243723 | |
496 | Phosphorylation | QPVPTELSLASITVP CCCCCEEEEEEEEEE | 18.69 | 30243723 | |
499 | Phosphorylation | PTELSLASITVPLES CCEEEEEEEEEEHHH | 24.88 | 30243723 | |
501 | Phosphorylation | ELSLASITVPLESIK EEEEEEEEEEHHHCC | 17.36 | 30243723 | |
506 | Phosphorylation | SITVPLESIKPSNIL EEEEEHHHCCHHHEE | 43.53 | 30243723 | |
546 | Phosphorylation | DVLVVVVSMLSTAPQ CEEEEEEECCCCCCC | 11.46 | 19276368 | |
550 | Phosphorylation | VVVSMLSTAPQPIRN EEEECCCCCCCCHHH | 38.09 | 19276368 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
355 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
355 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GGA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GGA1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND MASSSPECTROMETRY. |